Business
Why the Resonance Health (ASX:RHT) share price is shooting 39% higher today
The Resonance Health Limited (ASX: RHT) share price is shooting the lights out today. This comes after the company announced it has received a 510(k) clearance from the United States Food and Drug Administration (FDA) for its HepaFat-AI software.
At the time of writing, the Resonance Health share price is up 38.7% to 21.5 cents. In comparison, the All Ordinaires Index (ASX: XAO) is up 0.7% to 6,969 points.
What’s driving the Resonance Health share price?
The Resonance Health share price is surging today following the company’s positive FDA clearance announcement.
According to Resonance Health, the FDA has cleared the pathway for the company to begin commercialisation for its HepaFat-AI technology.
HepaFat-AI is a medical…
-
Noosa News21 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General15 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Business23 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
Noosa News21 hours agoAustralia’s most disaster-prone state urged to prepare ahead of storm, flood and fire season